Young Living LoginWiki info
In September 2014, the U. S. Food and Drug Administration warned Young Living against illegally marketing its products as possible treatments or cures for Ebola virus and other conditions, including "Parkinson’s disease, autism, diabetes, hypertension, cancer, insomnia, heart disease, post-traumatic stress disorder (PTSD), dementia, and multiple sclerosis", after they identified multiple instances of such claims being made by Young Living's distributors on social media and other websites. The letter named specific essential oil products "promoted for conditions that cause them to be drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U. S. C. § 321(g)(1)(B)], because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. " The warning further stated that the marketing and distribution of these essential oil products as drugs by Young Living without FDA approval are violations of the Act. Young Living subsequently agreed to address the violations cited by the FDA.